Company intelligence / Profile preview

Razor Genomics

Brisbane, California, United Statesrazorgenomics.com ↗

Ownership: Private
Development stage: Commercial

Overview

The RiskReveal/DetermaRx assay has been validated in multiple independent studies as a prognostic tool for early-stage NSCLC. It stratifies patients into high-, intermediate-, or low-risk of death within five years post-resection. Data indicate improved disease-free survival for high/intermediate-risk patients who receive adjuvant chemotherapy based on the test results.[3][4][8] The test has received positive coverage recommendations from CMS and supports precision management decisions.

Therapeutic areas: Oncology
Modalities: Molecular diagnostic assay (gene expression signature)Diagnostic test (not a therapeutic modality)
Industry: Molecular Diagnostics

Drug pipeline

1 asset

RiskReveal

Commercial

Indications: Stage IA-IIA non-squamous non-small cell lung cancer

Partnerships

Previously partnered with Oncocyte; now under Dragon Scientific ownership with Oncocyte as minority stakeholder

Beyond the preview

Go deeper on Razor Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Razor Genomics.

Explore the full profile